| Literature DB >> 35434312 |
Kirsty Biggs1,2, Gemma Crundwell3, Christopher Metcalfe1,4, Jameel Muzaffar4,5, Peter Monksfield4, Manohar Bance3,5.
Abstract
Objective: Establish anatomical considerations, audiological outcomes, and optimal management in patients with branchiootic/branchiootorenal syndrome (BO/BOR).Entities:
Keywords: audiology; branchiootorenal syndrome; otology/neurotology; systematic review
Year: 2022 PMID: 35434312 PMCID: PMC9008175 DOI: 10.1002/lio2.749
Source DB: PubMed Journal: Laryngoscope Investig Otolaryngol ISSN: 2378-8038
Diagnostic criteria
| Diagnostic criteria for BOR syndrome | |
|---|---|
| Major criteria | Minor criteria |
| Branchial anomalies | External ear anomalies |
| Deafness | Middle ear anomalies |
| Preauricular pits | Inner ear anomalies |
| Renal anomalies | Preauricular tags |
| Other: facial asymmetry, palate abnormalities | |
All affected individual must have at least three major criteria; two major criteria and at least two minor criteria, or one major and an affected first‐degree relative meeting criteria for BOR.
FIGURE 1PRISMA flow diagram
Summary of audiological outcomes, anatomical findings, and interventions
| Author | Sample | Type of hearing loss | Age | Degree | Pattern | Ear anatomy | Intervention | Outcomes | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Melnick et al |
| Mixed | Father = 44 years, children unknown | Variable | x | MD, stapes fixation, cup‐shaped pinnae | 1 = HA, auricular surgery | Difficulty in communicating despite HA ( |
| 2 | Fraser et al |
| Mixed, conductive, SN | 11 months–40 years | Mild–severe | Progressive | ME fluid, otosclerosis, ossicle hypoplasia and OC displacement, OM, protuberant auricles, cochlear hypoplasia | Case 1: myringotomies(B/L) for recurrent OM, HA and rehabilitation. Case 2: repeated stapedectomies | 4× unsuccessful stapedectomies ( |
| 3 | Cremers et al |
| Mixed, conductive | x | x | x | Cochlear hypoplasia/dysplasia, narrow or wide IAC, OC anomalies (not specified), SC (horizontal)hypoplasia, anomalous pinna | Exploratory tympanotomy in 6 patients (7 ears), Teflon interposition attempted in 3 patients | Middle ear surgery feasibly impractical to attempt ( |
| 4 | Smith et al |
| Mixed, conductive | 4–26 years | Mild–severe | Progressive, stable | Recurrent OM, fused incudomalleolar complex, absence of stapes and long process of the incus, cup‐shaped pinnae | Case 1: myringotomies with grommet insertion (B/L), exploratory tympanotomy and ossicular reconstruction with total ossicular replacement prosthesis. Case 2: myringotomies with grommet insertion (B/L) | Case 1: Persistent conductive loss after myringotomies, postossicular reconstruction: mild–moderate conductive loss on PTA, speech reception threshold: Right 88%, 35 dB; Left 88%, 30 dB. Case 2: interval PTA: mild low‐frequency conductive loss, speech reception threshold: Right, 88%, 10 dB; Left, 88%, 20 dB, being evaluated for HA |
| 5 | Slack et al |
| Mixed, SN | 6 months–26 years | Severe | Stable | Monopodal stapes, abnormal malleus and incus, IAC bulbous, cochlear hypoplasia with reduced turns, short and wide SC (lateral), lop ears | Exploratory tympanotomies in 2 cases, stapes reconstruction with interposed homograft incus between malleus handle and oval window | No improvement in hearing (numbers not included in paper) |
| 6 | Gimsing et al |
| Mixed, conductive, SN | 7–48 years | Mild–severe | Productive, stable | Malformed incus, absent stapes and oval window, under developed middle cavity, cochlear hypoplasia, cup‐shaped pinnae, microtia | Case 1: malformed incus replaced with homograft prosthesis. Case 2: non‐specified middle ear surgery (severely malformed) | Case 1: postoperative improvement in air bone gap below 2000 Hz, unchanged at higher frequencies. Case 2: air conduction threshold improved only 20 dB. |
| 7 | Lipkin et al |
| SN | 5 and 31 years | Mild–severe | Stable | Congenital cholesteatoma filling the sinus tympani, facial recess and ME, displaced ossicles | Firstt procedure: ME exploration and removal of a cholesteatoma, second procedure (1 year later): ossicular reconstruction with ceramic total ossicular replacement prosthesis. | No recurrence of cholesteatoma seen at second surgery |
| 8 | Martini et al |
| Mixed, conductive, SN | 4‐year‐adult | Mild–severe | x | Displaced OC, abnormal SC, labyrinth and cochlear hypoplasia with absent basal turn, cup‐shaped pinnae | Exploratory tympanotomy | x |
| 9 | Ostri et al |
| Mixed | x | Moderate–severe | Stable | Cochlear and SC hypoplasia, massive OC and reduced size of ME, auricular anomalies | HA in 16 cases | x |
| 10 | Dagglias et al |
| X | 2.5 years | Severe | x | EAC stenosis, bilateral ossicular mass fixation, malformed incus, B/L cochlear hypoplasia, dilated vestibules, SC (horizontal) hypoplasia, EED, IAC short and wide, cup‐shaped pinnae | HA | Normal speech |
| 11 | Cremers et al |
| Mixed, conductive | 16 years | Mild–severe | x | Curved EAC, no pneumatization of mastoid, absent stapes footplate and long process incus, nonmobile malleus, pinna dysplasia | Two operations: auricle reconstruction, and exploratory tympanotomy and mastoidectomy with creation of neo‐oval window | Significant hearing improvement at 2 yr follow‐up (55 dB to 15 dB PTA air bone gap closure), no complications |
| 12 | König et al |
| Mixed | x | Severe | x | Small incus and a very large antrum | x | x |
| 13 | Chen et al |
| Mixed, conductive, SN | x | Mild–profound | Productive, stable | Stenosis of the EAC, malformation of OC, cochlear hypoplasia/dysplasia, EED, lop ear deformity | x | x |
| 14 | Millman et al |
| x | 6 months | Severe | x | Normal otoscopy | x | x |
| 15 | Misra et al |
| Mixed | 44 years | Moderate–severe | x | Displaced and misshapen ossicles, facial nerve anomaly | HA (B/L) from childhood, 2 surgeries to left ear (age 27 and 33), followed by radical tympanomastoidectomy with facial nerve decompression | x |
| 16 | Graham et al |
| Mixed, conductive | 14 months, 36 years | Moderate | Stable | Cholesteatoma, absence/abnormality of the ossicles and oval window, lateralization of the malleus‐incus complex and the absence of contact with the stapes, facial nerve anomalies | Mother: HA + left exploratory tympanotomy age 16, infant: HA + surgical removal cholesteatoma at 10 months | Infant: inadequate postoperative healing and infection of mastoid process (requiring IV antibiotics) after successful cholesteotoma removal, with 3× OM episodes |
| 17 | Weber et al |
| Conductive, SN | newborn to 33 years | Mild–moderate | x | Cup‐shaped pinna | x | x |
| 18 | Worley e tal |
| Mixed | 3 years | Moderate | Stable | Cholesteatoma (B/L) OME and loss of ventilation tubes, deformed ME cavity (B/L), malformed ossicles with fused malleus and incus, SC and cochlear hypoplasia, microtia | Grommets inserted, HA (B/L), radical mastoidectomy w/o reconstruction, stenting of stenosed meatus required | Facial nerve function preserved postoperatively, manages well with HA (B/L). She attends a mainstream school with input from a teacher for the deaf |
| 19 | Prabhu et al |
| Mixed | 12 years | x | x | Pinna dysplasia (unilateral) | x | x |
| 20 | Usami et al |
| Mixed, conductive | x | Mild–severe | Stable | Cochlear and SC (lateral and posterior) hypoplasia (B/L), displaced OC, congenital cholesteatoma, cup‐shaped pinnae | Exploratory tympanotomy | x |
| 21 | Bamiou et al |
| SN | x | x | x | MD | x | x |
| 22 | Kemperman et al |
| Mixed, SN | 55 and 30 years | Profound | Progressive, fluctuant | Son: Abnormal configuration of OC, dysplastic long process of incus, incomplete stapedial crura, MD, wide IAC, plump vestibule, EVA, recurrent OME, Father: cochlear and vestibular hypoplasia, EVA, cup‐shaped pinnae | Son: HA, Grommets inserted for OME, myringoplasty to repair perforation, exploratory tympanotomy w/o reconstruction | Recurrent OE from HA. Progressive loss over 23 years (29 audiograms), regression analysis was performed for air conduction and showed that progression was generally significant at all frequencies. However (after exclusion of the first audiogram), progression may have been nonlinear; the runs test was significant at 0.25 to 2 kHz in the left ear and at 0.25 kHz in the right ear. Progression in bone conduction thresholds was significant at 0.5 and 1 kHz in both ears and at 2 kHz in the left ear. Independently of age, the air‐bone gap in both ears was 30 to 60 dB at 0.5 to 1 kHz and under 40 dB at the higher frequencies. Thus, the air‐bone gap did not show any substantial progression, but it did show considerable fluctuation |
| 23 | Bellini et al |
| Mixed, conductive, SN | <1 months | x | x | Lop‐ear deformity | x | x |
| 24 | Stinckens et al |
| SN | 1–35 years | x | Progressive, stable | EVA, cochlear hypoplasia | x | x |
| 25 | Klingebiel et al |
| SN | x | x | x | SC (superior) dysplasia, cochlear hypoplasia, EVA, | x | x |
| 26 | Fukuda et al |
| Mixed, SN | x | Mild‐profound | x | OME | Tympanotomy for effusion | x |
| 27 | Kemperman et al |
| Mixed, SN | x | x | Progressive, fluctuant | EES/D, cochlea and labyrinth hypoplasia, malformed auricles, fluid in ME, EAC atresia | B/L correction of malformed auricles ( | x |
| 28 | Pierides et al |
| x | x | Variable | Progressive | EE malformations‐ asymmetric + cup‐shaped | x | x |
| 29 | Ceruti et al |
| SN | 5–39 years | Variable | Progressive | Cochlear hypoplasia/dysplasia, B/L cochlear nerve hypoplasia, SC and OC malformations, EVA, EES/D | x | x |
| 30 | Yashima et al |
| Mixed, SN | 18–53 years | Mild–moderate | x | Mild stapes deformity, EVA, common cavity of vestibule (B/L), cup shaped pinnae | x | x |
| 31 | Kemperman et al |
| X | 16–79 years | x | Progressive, fluctuant | EVA, cochlear hypoplasia | x | x |
| 32 | Propst et al |
| X | 0.9–42.8 years | x | x | Cochlea hypoplasia (apical turn), medially deviated facial nerve, funnel‐shaped IAC, patulous eustachian tube, abnormal incus ligaments, malleoincudal anomalies | x | x |
| 33 | Rana et al |
| X | 6 years | x | x | Poorly pneumatized mastoids, partial agenesis of EAC (B/L), malformed (cupped) auricles (B/L) | x | x |
| 34 | Kim et al |
| Mixed | 3 and 30 years | Moderate profound | x | EAC stenosis, poor pneumatisation and dense mass in the mastoid and ME cavity, cochlear hypoplasia, EVA, OC malformation, OM, bilateral cup‐shaped anteverted microtia | HA and auditory rehabilitation | x |
| 35 | Ito et al |
| Mixed | 18 years | Moderate | Progressive | EVA, enlarged vestibule, middle and inner ear malformations | x | x |
| 36 | Kameswaran et al |
| SN | 3 years | Profound | x | Severe vestibular dysplasia, dilated SC and malformed ossicles (B/L), cup‐shaped ears, contracted mastoid antrum | HA at 1 year, At 3 years CI: Nucleus 24 channel straight array was inserted and 19 electrodes, cochleostomy was sited more antero‐superior to the round window | No intraoperative complications, good improvement with closed‐set speech recognition |
| 37 | Dogru et al |
| Mixed | 20 yeasrs | Moderate | x | Increased mastoid pneumatization (B/L) | x | x |
| 38 | Matsunaga et al |
| Mixed | 31–65 years | Mild–severe | Stable | EVA, cochlear hypoplasia, abnormal ossicles, enlarged vestibule, lop‐ear deformity | HA from infancy, ossicular reconstruction | Manipulation within the tympanic cavity was suspended after difficulties, with failed improvement of hearing |
| 39 | Sanggaard et al |
| SN | x | Mild–profound | Progressive | External, middle and inner ear anomalies (nonspecified) | x | x |
| 40 | Garg et al |
| x | 19 years | Profound | x | Low set, lop‐ears | HA | Good response |
| 41 | Senel et al |
| Mixed, conductive | 6 and 44 years | Mild–moderate | x | Cochlear and SC hypoplasia, OC malformation, enlarged IAC (B/L), unilateral malleus and incus hypoplasia | Operations for hearing loss scheduled for both patients | x |
| 42 | Ayçiçek et al |
| Mixed, conductive, SN | 18–75 years | x | x | Prominent ear deformity | x | x |
| 43 | Johnston et al |
| Mixed | 12 months | Moderate–severe | x | ME dermoid cyst, displaced malleus, malformed ossicles, medially located and opacified ME space, funnel‐shaped EVA, defect in tympanic plate | HA (B/L), Myringotomy with grommet insertion for bilateral OME, transmastoid and transcanal exploration of whitish mass |
At 6 months, good healing and audiogram was unchanged (PTA showed R moderately to mild mixed loss, L profound‐severe loss). The patient was wearing binaural aids and participated in mixed signing and spoken English |
| 44 | Bisanna et al |
| SN | 16 years | Moderate–severe | Progressive | Cholesteatoma, partially destroyed malleus and incus, sclerotic mastoid, perforated TM, cup‐shaped pinnae, low set ear | Cholesteatoma removed with radical mastoidectomy | x |
| 45 | Noguchi et al |
| Mixed | 21 years | Moderate | Stable | EVA (B/L) | HA | x |
| 46 | Song et al |
| Mixed | 1‐43 years | Moderate–severe | Progressive | Cochlear hypoplasia, EVA, dilated vestibule, facial nerve anomaly, malformed/misaligned/fused ossicles, IAC bulbous/funnel | HA ( | All ME surgeries were unsuccessful, 8/10 benefitted from HA, 2 who did not benefit went on to have successful outcomes with CI (hearing and language ability) |
| 47 | Jankauskienè et al |
| x | 4 days | x | x | x | x | x |
| 48 | Lapeña et al |
| x | 6 years | Moderate–severe | x | x | HA (B/L) at age 3 years | x |
| 49 | Castiglione et al |
| Conductive | 9 and 30 years | Mild | Progressive | Mild auricular anomalies, normal otoscopy, hypoplastic/dysplastic SC, dilated/bulbous IAC, FN deviation, large mastoid emissary vein, dysplastic incus and hypoplastic long process, patulous Eustachian tube, hypoplastic/dysplastic cochlea | No intervention required | x |
| 50 | Jalil et al |
| Conductive | 8 years | x | Progressive | OME | Grommets, HA and rehabilitation | No improvement with grommets |
| 51 | Morisada et al |
| Mixed, conductive, SN | x | x | x | EAC stenosis, pinnae deformities | HA ( | 80% success with HA, 64% (7/11) success with surgery |
| 52 | Schmidt et al |
| SN | 43 years | x | Progressive | Enlarged Eustachian tubes, absent mastoid cells | HA at age 3 years | x |
| 53 | Ječmenica et al |
| Conductive | 4 years | Severe | x | x | HA for air conduction | Subjective speech improvements, but intelligibility is still not satisfying |
| 54 | Ginat et al |
| Mixed | 50 years | Profound | Progressive | Extensive ossicular anomalies (B/L), ectopic and dysmorphic right incudo‐malleal complex projecting into the middle cranial fossa, cochlear hypoplasia (B/L), malformed vestibules and SC (lateral and posterior), ICA canal hypoplasia, high‐riding jugular bulb up to the round window, dysmorphic IAC, anomalous positioning of the facial nerve canals | HA (B/L) from childhood, unilateral CI at 50 years, CI with compressed array of electrodes (round window approach) | HA not sufficient, excellent subjective improvement with CI, no complications. Initial postoperative sound detection thresholds at 40 dB or less 250–2000 Hz and 50 dB or less for 4000–6000 Hz |
| 55 | Unzaki et al |
| Mixed, conductive, SN | 0–60 years | x | x | Inner, middle, external, and EAC anomalies (nonspecified) | x | x |
| 56 | Nasir et al |
| Mixed | 4 years | Severe | x | x | HA (B/L) | x |
| 57 | Hsu et al |
| Mixed, conductive, SN | 1–14 years | x | x | Unwound cochlear dysmorphology, funnel IAC, EVA, medialized facial nerve | x | x |
| 58 | Parkes et al |
| x | 0.5–42.8 years | x | x | Abnormally located/absent Koerner's septum (45%), severely hypoplastic/absent antrum (50%), dysplastic short process of incus (62%), dysplastic SC (73%) | x | x |
| 59 | Wang et al |
| Mixed, conductive | x | x | x | ME malformation (B/L), cochlear and SC (posterior) hypoplasia, OM (B/L), microtia | x | x |
| 60 | Chen at al |
| Mixed | x | Profound | Progressive | Cochlear hypoplasia, stenosis of cochlear nerve canal orifice, displaced and deformed ossicles, mastoid cells hypoplasia | x | x |
| 61 | Mironovich et al |
| Conductive, SN | 3–38 years | Mild–severe | x | EVA + EES, cochlear hypoplasia, dysplastic SC, dilated IAC, ossicle malformations, protruding ears | x | x |
| 62 | Men et al |
| x | x | Profound | x | EVA, EES, MD, cochlear fusion, ME anomalies, cup shaped pinnae, low set ear | 1 CI | Easy electrode implantation, no complications, Preoperatively, auditory brainstem response demonstrated bilateral profound hearing loss. At 4 months postimplantation, the patient had pure tone average of 55–70 dB in free‐field conditions and thresholds for Ling sounds of 55–70 dB at 6 months. Good progression in listening comprehension |
| 63 | Li et al |
| Mixed | 7 years | Moderate | x | Auricular anomalies (dysplasia, anterior auricular fistulas, auricular appendix), EAC stenosis, OM papillae, microtia, pinnae deformity, ankylotia | EAC formation, and tympanoplasty | Significant improvement in hearing 1‐year postoperative. Preoperative hearing threshold: 56.25 (right) and 62.5 dB (left) hearing level in air conduction. Postoperative: 52.5 (right) and 25 dB (left) |
| 64 | Xing et al |
| Mixed | 1.5–51 years | x | Stable | Cochlear hypoplasia (B/L), narrow EAC, ossicular dysplasia, microtia, auricular malformation | BAHA for 2 cases | Good response |
Study reports six families, four of which are already included by Ostri and Gimsing.
Abbreviations: EAC, external auditory canal; EED, external ear deformity; EVA, enlarged ventricular aqueduct; IAC, internal auditory canal; MD, Meniere's disease; ME, middle ear; OC, ossicular chain; OME, otitis media with effusion; PTA, pure tone audiogram; SN, sensorineural hearing loss.
FIGURE 2. Ear anomalies according to genetics
Summary of interventions and reported outcomes
| Beneficial outcome | Beneficial | Nonbeneficial | |
|---|---|---|---|
| HA alone | 8/13 |
|
|
| BAHA | 2/2 |
| x |
| CI | 5/5 |
| x |
| Middle ear surgery | 11/30 |
52.5 (right) and 25 dB (left) ( |
|
| HA + surgery | 2/6 |
|
|
Abbreviations: BAHA, bone‐anchored hearing aid; CI, cochlear implantation; HA, Hearing aid.
Tabular representation of Brazelli Risk of Bias Tool
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Melnick et al | 1976 | Yes | No | No | Yes | No | NA | No | Unclear | Unclear | Yes | No | No | Unclear | No | Yes | NA | Yes | NA |
| Fraser et al | 1978 | Yes | No | No | Yes | No | NA | Yes | Unclear | Unclear | Yes | No | No | Unclear | No | Yes | NA | Yes | NA |
| Cremers et al | 1980 | Yes | no | no | yes | no | n/a | yes | unclear | unclear | yes | no | no | no | no | yes | n/a | yes | n/a |
| Smith et al | 1984 | No | No | No | No | No | NA | Yes | Unclear | Unclear | Yes | Yes | No | Yes | No | Yes | NA | Yes | NA |
| Slack et al | 1985 | Yes | No | No | Yes | No | NA | Yes | Yes | Yes | Yes | Yes | No | Unclear | No | Yes | NA | Yes | NA |
| Gimsing et al | 1986 | Yes | No | No | Yes | No | NA | No | Yes | Yes | Yes | Yes | No | Unclear | No | Yes | NA | Yes | NA |
| Lipkin et al | 1986 | No | No | Yes | No | No | NA | Yes | Unclear | Unclear | Yes | No | No | No | No | Yes | NA | Yes | NA |
| Martini et al | 1987 | No | No | No | Unclear | No | NA | Yes | Unclear | Unclear | No | No | No | NA | No | Yes | NA | Yes | NA |
| Ostri et al | 1991 | Yes | No | No | Yes | No | NA | No | NA | NA | Yes | No | No | No | No | Yes | NA | Yes | NA |
| Dagglias et al | 1992 | No | No | NA | NA | No | NA | No | Unclear | Unclear | Yes | No | No | No | No | Yes | NA | Yes | NA |
| Cremers et al | 1993 | No | No | No | Unclear | No | NA | Yes | Yes | Yes | Yes | Yes | No | Yes | No | Yes | NA | Yes | NA |
| König et al | 1994 | No | No | Yes | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Chen et al | 1995 | Yes | Unclear | No | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Millman et al | 1995 | No | No | NA | NA | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Misra et al | 1998 | No | No | NA | NA | No | NA | No | Unclear | Unclear | No | No | No | No | No | Yes | NA | Yes | NA |
| Graham et al | 1999 | No | No | No | Yes | No | NA | Yes | Unclear | Unclear | Yes | No | No | No | No | Yes | NA | Yes | NA |
| Weber et al | 1999 | No | No | No | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Worley e tal | 1999 | No | No | NA | NA | No | NA | Yes | Yes | Yes | Yes | No | No | Yes | No | Yes | NA | Yes | NA |
| Prabhu et al | 1999 | No | No | NA | NA | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Usami et al | 1999 | No | No | No | No | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Bamiou et al | 2000 | Yes | Yes | Yes | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Kemperman et al | 2001 | No | No | No | Yes | No | NA | Yes | Unclear | Unclear | Yes | Yes | No | Yes | No | Yes | NA | Yes | NA |
| Bellini et al | 2001 | Yes | Yes | Unclear | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Stinckens et al | 2001 | Yes | No | No | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Klingebiel et al | 2001 | Yes | Yes | Unclear | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Fukuda et al | 2001 | No | No | No | Yes | No | NA | Yes | Unclear | Unclear | No | No | No | No | No | Yes | NA | Yes | NA |
| Kemperman et al | 2002 | Yes | Yes | No | Yes | No | NA | Yes | Unclear | Unclear | Yes | No | No | No | No | Yes | NA | No | NA |
| Pierides et al | 2002 | Yes | No | Yes | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Ceruti et al | 2002 | Yes | Yes | Yes | Yes | Yes | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Yashima et al | 2003 | No | No | No | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Kemperman et al | 2004 | Yes | Yes | No | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Propst et al | 2005 | Yes | Yes | Unclear | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Rana et al | 2005 | No | No | NA | NA | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Kim et al | 2005 | No | No | no | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Ito et al | 2006 | No | No | NA | NA | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Kameswaran et al | 2007 | No | No | NA | NA | No | NA | Yes | Unclear | Unclear | Yes | No | No | No | No | Yes | NA | Yes | NA |
| Dogru et al | 2007 | No | No | NA | NA | No | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA | |
| Matsunaga et al | 2007 | No | No | Yes | Yes | No | NA | Yes | Yes | Yes | Yes | No | No | No | No | Yes | NA | Yes | NA |
| Sanggaard et al | 2007 | Yes | No | No | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Garg et al | 2008 | No | No | NA | NA | No | NA | Yes | Yes | Yes | Yes | No | No | Unclear | No | Yes | NA | Yes | NA |
| Senel et al | 2009 | No | No | No | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Ayçiçek et al | 2010 | No | No | Yes | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Johnston et al | 2011 | No | No | NA | NA | No | NA | Yes | Yes | Yes | Yes | Yes | No | No | No | Yes | NA | Yes | NA |
| Bisanna et al | 2011 | No | No | NA | NA | No | NA | Yes | Yes | Yes | Yes | No | No | No | No | Yes | NA | Yes | NA |
| Noguchi et al | 2011 | No | No | NA | NA | No | NA | Yes | Yes | Yes | No | No | No | No | No | Yes | NA | Yes | NA |
| Song et al | 2013 | Yes | Yes | No | Yes | No | NA | Yes | Unclear | Unclear | Yes | No | No | Unclear | No | Yes | NA | Yes | NA |
| Jankauskienè et al | 2013 | No | No | NA | NA | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Lapeña et al | 2013 | No | No | NA | NA | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Castiglione et al | 2014 | Yes | Yes | No | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Jalil et al | 2014 | No | No | NA | NA | No | NA | Yes | Yes | Yes | Yes | No | No | No | No | Yes | NA | No | NA |
| Morisada et al | 2014 | Yes | Yes | Yes | Yes | No | NA | No | Unclear | Unclear | Yes | No | No | No | No | Yes | NA | No | NA |
| Schmidt et al | 2014 | No | No | NA | NA | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Ječmenica et al | 2015 | No | No | NA | NA | No | NA | Yes | Unclear | Yes | Yes | No | No | Unclear | No | Yes | NA | No | NA |
| Ginat et al | 2016 | No | No | NA | NA | No | NA | Yes | Yes | Yes | Yes | Yes | No | No | No | Yes | NA | Yes | NA |
| Unzaki et al | 2018 | Yes | Yes | Unclear | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Nasir et al | 2018 | No | No | NA | NA | No | NA | Yes | NA | NA | No | No | No | No | No | Yes | NA | No | NA |
| Hsu et al | 2018 | Yes | Yes | Unclear | Yes | No | NA | NA | NA | NA | Yes | NA | No | NA | No | Yes | NA | Yes | NA |
| Parkes et al | 2018 | Yes | Yes | Unclear | Yes | No | NA | NA | NA | NA | Yes | NA | No | NA | No | Yes | NA | Yes | NA |
| Wang et al | 2018 | No | Yes | No | Yes | No | NA | NA | NA | NA | Yes | NA | No | NA | No | Yes | NA | No | NA |
| Chen at al | 2019 | No | No | Unclear | Yes | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | No | NA |
| Mironovich et al | 2019 | No | No | No | No | No | NA | NA | NA | NA | NA | NA | No | NA | No | Yes | NA | Yes | NA |
| Men et al | 2020 | No | No | Yes | Yes | No | NA | Yes | Yes | Yes | Yes | Yes | No | No | No | Yes | NA | Yes | NA |
| Li et al | 2020 | No | No | NA | NA | No | NA | Yes | Unclear | Yes | Yes | Yes | No | Yes | No | Yes | NA | Yes | NA |
| Xing et al | 2020 | No | No | No | Yes | No | NA | Yes | Unclear | Unclear | Yes | No | No | Unclear | No | Yes | NA | No | NA |
Note: 1. Were participants a representative sample selected from a relevant patient population (e.g., randomly selected from those seeking treatment despite age, duration of disease, primary or secondary disease, and severity of disease)?, 2. Were the inclusion/exclusion criteria of participants clearly described?, 3. Were participants entering the study at a similar point in their disease progression (i.e., severity of disease)?, 4. Was selection of patients consecutive?, 5. Was data collection undertaken prospectively?, 6. Were the groups comparable on demographic characteristics and clinical features?, 7. Was the intervention (and comparison) clearly defined?, 8. Was the intervention undertaken by someone experienced at performing the procedure? (“Yes” if the practitioner received training on conducting the procedure before or conducted same kind of procedure before [i.e., no learning curve].), 9. Were the staff, place, and facilities where the patients were treated appropriate for performing the procedure (e.g., access to back‐up facilities in hospital or special clinic)?, 10. Were any of the important outcomes considered (i.e., on clinical effectiveness, cost‐effectiveness, or learning curves)?, 11. Were objective (valid and reliable) outcome measures used, including satisfaction scale?, 12. Was the assessment of main outcomes blind?, 13. Was follow‐up long enough (≥1 year) to detect important effects on outcomes of interest?, 14. Was information provided on nonrespondents, dropouts? (“No” if participants were those whose follow‐up records were available [retrospective].), 15. Were the characteristics of withdrawals/dropouts similar to those that completed the study and therefore unlikely to cause bias? (“Yes” if no withdrawal/dropout; “No” if dropout rate ≥30% or differential dropout), 16. Was length of follow‐up similar between comparison groups?, 17. Were the important prognostic factors identified (e.g., age, duration of disease, and disease severity)? (“Yes” if two or more than two factors were identified.), 18. Were the analyses adjusted for confounding factors?